Bosh sahifaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
38,80 $
Seans yopilganidan keyin:(0,00%)0,00
38,80 $
Yopilgan:22-avg, 20:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
38,20 $
Kunlik diapazon
37,75 $ - 39,69 $
Yillik diapazon
23,42 $ - 62,58 $
Bozor kapitalizatsiyasi
2,25 mlrd USD
Oʻrtacha hajm
880,78 ming
Narx/foyda
3,51
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 12,46 mln | 44,57% |
Joriy xarajat | 45,87 mln | 29,08% |
Sof foyda | -112,02 mln | -16,54% |
Sof foyda marjasi | -899,40 | 19,39% |
Har bir ulushga tushum | -1,93 | -14,20% |
EBITDA | -125,80 mln | -20,70% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 938,94 mln | 64,76% |
Jami aktivlari | 1,47 mlrd | 90,31% |
Jami passivlari | 101,68 mln | -9,66% |
Umumiy kapital | 1,37 mlrd | — |
Tarqatilgan aksiyalar | 58,10 mln | — |
Narxi/balansdagi bahosi | 1,62 | — |
Aktivlardan daromad | -20,99% | — |
Kapitaldan daromad | -21,62% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -112,02 mln | -16,54% |
Operatsiyalardan naqd pul | -77,12 mln | -6,25% |
Sarmoyadan naqd pul | 78,97 mln | 112,02% |
Moliyadan naqd pul | 65,00 ming | -94,09% |
Naqd pulning sof oʻzgarishi | 1,91 mln | 105,57% |
Boʻsh pul | -51,97 mln | -32,43% |
Haqida
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tashkil etilgan
2008
Sayt
Xodimlar soni
487
